Eagle Pharmaceuticals Inc... (EGRX)
0.94
-0.06 (-6.00%)
At close: Mar 27, 2025, 10:53 AM
0.88
-6.88%
After-hours: Mar 28, 2025, 04:00 PM EDT
Eagle Pharmaceuticals Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -2.67M | 35.64M | -8.63M | 11.99M | 14.31M | 31.9M | 51.94M | 81.45M | 2.57M | -17.98M | -6.05M | -19.38M |
| Depreciation & Amortization | 16.67M | 12.02M | 3.76M | 4.77M | 4.65M | 3.67M | 3.75M | 1.59M | 112K | 104K | 134.99K | 240K |
| Stock-Based Compensation | n/a | 16.45M | 19.55M | 24.76M | 22M | 19.08M | 15.43M | 9.77M | 4.05M | 606K | 317.19K | 402K |
| Other Working Capital | n/a | 19.8M | 3.68M | 4.63M | -1.37M | 12.4M | -7.1M | -15.75M | 11.03M | 3.45M | 875.38K | 3.18M |
| Other Non-Cash Items | -14M | 11.31M | 7.61M | 8.68M | 480K | 8.09M | 80K | -793K | 4.05M | 573K | 1.5M | 327K |
| Deferred Income Tax | 29.93M | -8.32M | -3.62M | -1.51M | 152K | -2.47M | 17.29M | -30.12M | -3.78M | n/a | 1.05M | 51K |
| Change in Working Capital | 866K | -16.4M | 9.54M | 816K | 14.39M | -7.89M | -29.57M | -8.69M | -16.73M | 2.85M | -2.83M | 2.81M |
| Operating Cash Flow | 30.8M | 50.7M | 28.22M | 49.5M | 55.99M | 52.38M | 58.92M | 53.21M | -9.72M | -13.84M | -5.88M | -15.55M |
| Capital Expenditures | n/a | -178K | -323K | -747K | -777K | -133K | -5.19M | -20.69M | -1.88M | -46K | -40.55K | -33K |
| Acquisitions | n/a | -74.15M | n/a | n/a | n/a | n/a | n/a | -26.86M | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | -12.5M | n/a | -17.5M | n/a | n/a | n/a | -62M | -106M | -20M | n/a | n/a |
| Sales Maturities Of Investments | n/a | 74.15M | n/a | n/a | n/a | n/a | n/a | 62M | 106M | n/a | 1.5M | n/a |
| Other Investing Acitivies | n/a | -74.15M | -5M | -17.5M | n/a | n/a | -750K | 1.75M | n/a | n/a | 1.5M | 3M |
| Investing Cash Flow | n/a | -86.83M | -5.32M | -18.25M | -777K | -133K | -5.19M | -45.8M | -1.88M | -20.05M | 1.46M | 2.97M |
| Debt Repayment | n/a | 12.76M | -8M | -5M | -6M | -3.75M | 48.75M | n/a | n/a | n/a | n/a | 9.66M |
| Common Stock Repurchased | n/a | -18M | -21.21M | -35M | -17.96M | -73.11M | -43.79M | -37M | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | -969K | 821K | 2.13M | -264K | -11.26M | 3.15M | 3.33M | 1.48M | 85K | 9.81M | -115K |
| Financial Cash Flow | n/a | -6.21M | -28.39M | -37.87M | -24.23M | -88.12M | 8.1M | -33.67M | 55.81M | 46.15M | 9.81M | 9.55M |
| Net Cash Flow | 30.8M | -42.34M | -5.5M | -6.62M | 30.98M | -35.87M | 61.84M | -26.26M | 44.21M | 12.27M | 5.39M | -3.03M |
| Free Cash Flow | 30.8M | 50.52M | 27.9M | 48.75M | 55.21M | 52.25M | 53.73M | 32.52M | -11.6M | -13.89M | -5.92M | -15.58M |